Key risks
Operating margins have compressed from 7.9% in Mar 2021 to 2.1–3.5% in recent quarters, eroding profitability while revenue has remained flat—understand whether this is cyclical or structural.
Net profit turned negative in Q3 FY26 (Dec 2025, –₹0.14 Cr), signalling acute cost or pricing pressure; verify if this reflects one-time items or recurring profitability stress.
Stock valuation at PE 37.62 appears stretched against ROE of 4.36% and volatile earnings; clarify what recovery management expects and over what timeline.
EPS has halved from ₹20.53 (Mar 2025) to ₹5.43 (Mar 2026). Determine whether this is driven by share issuance, lower net profit, or accounting changes.
Generated analysis · source review pending